318 related articles for article (PubMed ID: 29356979)
1. Analysis of US FDA-Approved Drugs Containing Sulfur Atoms.
Scott KA; Njardarson JT
Top Curr Chem (Cham); 2018 Jan; 376(1):5. PubMed ID: 29356979
[TBL] [Abstract][Full Text] [Related]
2. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery.
Ilardi EA; Vitaku E; Njardarson JT
J Med Chem; 2014 Apr; 57(7):2832-42. PubMed ID: 24102067
[TBL] [Abstract][Full Text] [Related]
3. Beyond C, H, O, and N! Analysis of the elemental composition of U.S. FDA approved drug architectures.
Smith BR; Eastman CM; Njardarson JT
J Med Chem; 2014 Dec; 57(23):9764-73. PubMed ID: 25255063
[TBL] [Abstract][Full Text] [Related]
4. Carboxylic Acid Counterions in FDA-Approved Pharmaceutical Salts.
Bharate SS
Pharm Res; 2021 Aug; 38(8):1307-1326. PubMed ID: 34302256
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in pharmaceutical salts: FDA approvals from 2015 to 2019.
Bharate SS
Drug Discov Today; 2021 Feb; 26(2):384-398. PubMed ID: 33221522
[TBL] [Abstract][Full Text] [Related]
6. Clinical and regulatory features of drugs not initially approved by the FDA.
Wang B; Avorn J; Kesselheim AS
Clin Pharmacol Ther; 2013 Dec; 94(6):670-7. PubMed ID: 23963252
[TBL] [Abstract][Full Text] [Related]
7. New Drugs Approved in 2022.
Ebied AM; Elmariah H; Cooper-DeHoff RM
Am J Med; 2023 Jun; 136(6):545-550. PubMed ID: 36889492
[TBL] [Abstract][Full Text] [Related]
8. Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases.
Xu K; Coté TR
Brief Bioinform; 2011 Jul; 12(4):341-5. PubMed ID: 21357612
[TBL] [Abstract][Full Text] [Related]
9. New Drugs Approved in 2021.
Ebied AM; Elmariah H; Cooper-DeHoff RM
Am J Med; 2022 Jul; 135(7):836-839. PubMed ID: 35235820
[TBL] [Abstract][Full Text] [Related]
10. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
11. From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles.
Delost MD; Smith DT; Anderson BJ; Njardarson JT
J Med Chem; 2018 Dec; 61(24):10996-11020. PubMed ID: 30024747
[TBL] [Abstract][Full Text] [Related]
12. The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
G de la Torre B; Albericio F
Molecules; 2019 Feb; 24(4):. PubMed ID: 30813407
[TBL] [Abstract][Full Text] [Related]
13. Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014).
Gnanasakthy A; DeMuro C; Clark M; Haydysch E; Ma E; Bonthapally V
J Clin Oncol; 2016 Jun; 34(16):1928-34. PubMed ID: 27069082
[TBL] [Abstract][Full Text] [Related]
14. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
[TBL] [Abstract][Full Text] [Related]
15. U.S. FDA Approved Drugs from 2015-June 2020: A Perspective.
Bhutani P; Joshi G; Raja N; Bachhav N; Rajanna PK; Bhutani H; Paul AT; Kumar R
J Med Chem; 2021 Mar; 64(5):2339-2381. PubMed ID: 33617716
[TBL] [Abstract][Full Text] [Related]
16. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.
Sacks LV; Shamsuddin HH; Yasinskaya YI; Bouri K; Lanthier ML; Sherman RE
JAMA; 2014 Jan 22-29; 311(4):378-84. PubMed ID: 24449316
[TBL] [Abstract][Full Text] [Related]
17. Canadian, European and United States new drug approval times now relatively similar.
Rawson NSB
Regul Toxicol Pharmacol; 2018 Jul; 96():121-126. PubMed ID: 29730446
[TBL] [Abstract][Full Text] [Related]
18. Comparing patient access to pharmaceuticals in the UK and US.
Cohen J; Cairns C; Paquette C; Faden L
Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
[TBL] [Abstract][Full Text] [Related]
19. Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.
Ali S; Bolinger AA; Zhou J
Curr Top Med Chem; 2024; 24(10):843-849. PubMed ID: 38445700
[TBL] [Abstract][Full Text] [Related]
20. 2014 in review: FDA approval of new drugs.
Kinch MS
Drug Discov Today; 2017 Apr; 22(4):620-624. PubMed ID: 26100738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
